Atlas Trials

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus

Clinical trial NCT03510624 · COMPLETED

Trial details

NCT number
NCT03510624
Sponsor
Universitaire Ziekenhuizen KU Leuven
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2018-11-09
Primary completion
2021-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.